Alzheimers

Prodromal Alzheimer’s disease marks a crucial phase within the Alzheimer’s continuum where individuals begin to experience mild cognitive impairments that may herald the onset of dementia. While Alzheimer’s is fundamentally recognized as a type of dementia characterized by progressive cognitive decline, the emphasis on identifying preclinical and prodromal stages is gaining traction among researchers and

Alzheimer’s disease stands as the leading cause of dementia, a condition characterized by a decline in cognitive functions such as memory, communication, and daily task performance. This neurological disorder progressively diminishes brain health, resulting in challenges that severely impact the lives of those affected and their caregivers. Despite the absence of a definitive cure, various

Essential tremor (ET) is a neurological condition characterized by involuntary shaking, primarily affecting the hands, head, and voice. Unlike the well-known Parkinson’s disease, ET often remains under-recognized, yet it significantly impacts daily activities such as eating, writing, and personal grooming. Approximately 25 million individuals globally suffer from this disorder, which can increasingly hinder their quality

Alzheimer’s disease (AD) stands as one of the most challenging forms of dementia, presenting a progressive decline in cognitive and physical abilities that deeply impacts individuals and their families. The Reisberg Functional Assessment Screening Tool, commonly referenced as the FAST scale, has been designed to aid healthcare professionals in diagnosing and tracking the disease’s progression,

Kisunla, a recently approved injectable medication, has garnered attention due to its effectiveness in specific treatments. However, like many pharmaceuticals, it carries potential side effects that patients and healthcare providers must be aware of. In this article, we delve into the common and serious side effects linked with Kisunla, emphasizing the importance of communication between

Mobility refers to one’s ability to move, encompassing aspects such as stamina, strength, balance, coordination, and range of motion of the joints. On the other hand, disability is the outcome of an impairment that hinders a person from carrying out tasks in a typical manner within their culture. Disabilities can affect various functions, including movement,

Namenda, also known as memantine, is a medication commonly prescribed for Alzheimer’s disease in adults. This drug belongs to a class of medications called N-methyl D-aspartate (NMDA) antagonists. It is available in both brand-name and generic versions, with different strengths and forms. Namenda comes in two oral forms: an immediate-release (IR) tablet and an extended-release

The connection between autism and Alzheimer’s disease is a topic that has garnered increasing attention in recent years. Although these are distinct neurological conditions with varying characteristics, there is emerging evidence suggesting a potential link between the two. While autism primarily affects social interaction, communication, and behavior in individuals, Alzheimer’s disease is a progressive neurodegenerative

Alzheimer’s disease is a progressive condition that affects the brain, leading to symptoms such as memory loss, cognitive difficulties, and changes in behavior and personality. Individuals in the early stages of Alzheimer’s disease may find it challenging to carry out day-to-day activities and may require assistance to ensure their health and safety. In such cases,

When it comes to managing Alzheimer’s disease in adults, Namenda (memantine hydrochloride) is a common prescription drug that is used. However, like any medication, Namenda can come with its own set of side effects. These side effects can range from mild to severe, and it is important for individuals to be aware of them when